Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigous | ||
| Readability |
H.S. junior Avg
|
|
New words:
absent, amyotrophic, BBA, Bellina, Bipartisan, box, burdensome, Cadillac, Canton, cantonal, cGCP, citing, CMS, CSR, disagreement, district, donut, EU, excise, feet, framework, Frank, heightened, hole, incorrectly, innervation, IRS, Jordan, Justice, licensedproduct, Matthew, McLinn, Mongiello, narrative, neuromuscular, nonrecurring, November, Parliament, partnering, PET, priority, readout, referendum, rent, robust, run, software, space, square, susceptible, temporarily, thousand, Trickett, Wendler, York
Filing tables
Filing exhibits
Related press release
SIOX similar filings
Filing view
External links
Exhibit 32.2
CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report on Form 10-Q of Axovant Sciences Ltd. (the “Company”) for the period ended September 30, 2018 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), the undersigned, Gregory Weinhoff, Principal Financial Officer of the Company, hereby certifies, pursuant to 18 U.S.C. Section 1350, that to his knowledge:
(1)the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2)the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
| Date: November 7, 2018 | By: | /s/ Gregory Weinhoff |
| Gregory Weinhoff | ||
| Principal Financial Officer | ||
A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the SEC or its staff upon request.